FFilingSight

Nucor Corp. (NUE) 10-K Red Flags

Risk signals extracted deterministically from Nucor Corp.’s SEC 10-K/10-Q XBRL filings — no LLM, every finding cites the underlying data.

Detected red flags (17)

  • Receivables outpacing revenue: Accounts receivable grew +16.1% YoY vs revenue growth of +5.7%. The +10.3% spread suggests extended credit terms, channel stuffing risk, or collection deterioration. Investigate the allowance for doubtful accounts and DSO trend.
  • Free cash flow deteriorating: FCF declined +123.3% YoY (from $806.0M to $-188.0M). With OCF at $3.23B and capex at $3.42B, cash generation capacity is weakening — monitor for dividend/buyback sustainability.
  • NEW: Going concern doubt in latest filing: The term "going concern" "substantial doubt" appears in recent 10-K/10-Q filings but was NOT present in the prior 24-month period. This is a new risk disclosure that warrants attention. Found in 5 filing(s).
  • NEW: Substantial doubt about ability to continue in latest filing: The term "substantial doubt" "ability to continue" appears in recent 10-K/10-Q filings but was NOT present in the prior 24-month period. This is a new risk disclosure that warrants attention. Found in 5 filing(s).
  • Restatement of financial statements: The term "restatement of" "previously issued" appears in 3 recent filing(s) (vs 3 in the prior period). This risk language is ongoing.
  • Operating cash flow exceeds net income: OCF is 1.85x net income, indicating high earnings quality — cash conversion is strong and accruals are not inflating reported profits.
  • Endogenous analysis: Revenue grew +5.7% but receivables grew +16.1% — the receivables-to-revenue gap suggests growth may be partially driven by extended credit terms rather than genuine demand. If DSO continues to rise, a revenue reversal or bad-debt charge could follow.
  • Endogenous analysis: Free cash flow declined despite stable or rising capex, indicating the cash burn is operational rather than investment-driven. This is a structural concern — cost reduction or asset sales may be needed to restore FCF.
  • Endogenous analysis: Strong cash conversion (OCF > NI) combined with growing deferred revenue provides high forward visibility. The business model appears to generate sustainable, recurring cash flows — a positive structural indicator.
  • 3 new XBRL disclosure(s) in latest filing — expanding reporting scope.
  • 20 disclosure(s) dropped from prior year — reduced reporting granularity.
  • 3 new risk-language term(s) detected in filing text: Going concern doubt, Substantial doubt about ability to continue, Restructuring.
  • Ongoing high-severity risk language: Restatement of financial statements.
  • Revenue grew **+5.7%** YoY to $32.49B.
  • 5-year revenue CAGR **-2.3%**; 10y CAGR +8.0%.
  • Receivables outpacing revenue: Accounts receivable grew +16.1% YoY vs revenue growth of +5.7%. The +10.3% spread suggests extended credit terms, channel stuffing risk, or collection deterioration. Investigate the allowance for doubtful accounts and DSO trend.
  • Free cash flow deteriorating: FCF declined +123.3% YoY (from $806.0M to $-188.0M). With OCF at $3.23B and capex at $3.42B, cash generation capacity is weakening — monitor for dividend/buyback sustainability.

Filings & ownership

  • Latest annual report (10-K) filed Feb 25, 2026.
  • Latest quarterly report (10-Q) filed Aug 12, 2026.
  • 8 recent 8-K material-event filings in the index.
  • Recent insider Form 4s: 0 buy vs 6 sell transactions — net selling $8.2M.
  • ~10,000+ recent 13F-HR filings reference Nucor Corp.; broad institutional reporting.
  • Recent filers include MARATHON ASSET MANAGEMENT LP, CTC Alternative Strategies, Ltd., MARATHON ASSET MANAGEMENT LP.
  • 20 recent 13G passive institutional ownership notices.

Full NUE analyst report

Valuation (DCF & Graham), technicals, macro exposure, risk scorecard and 13F/13D ownership.

View full report →

Not investment advice. FilingSight is an automated analytical research tool, not a registered investment advisor. Ratings and scores are quantitative analytical classifications, not buy or sell recommendations. Nothing here is personalized to your circumstances. Investing involves risk of loss — consult a licensed professional. See full disclosures.